PA
Profund Advisors Portfolio holdings
AUM
$2.78B
This Quarter Return
+2.54%
1 Year Return
+29.53%
3 Year Return
+153.44%
5 Year Return
+262.59%
10 Year Return
+738.89%
AUM
$2.2B
AUM Growth
+$2.2B
(-1.4%)
Cap. Flow
-$52.2M
Cap. Flow
% of AUM
-2.37%
Top 10 Holdings %
Top 10 Hldgs %
22.12%
Holding
1,814
New
117
Increased
618
Reduced
880
Closed
199
Top Buys
| 1 |
Gilead Sciences
GILD
|
$15.1M |
| 2 |
Amgen
AMGN
|
$12.7M |
| 3 |
AbbVie
ABBV
|
$11.1M |
| 4 |
Biogen
BIIB
|
$10M |
| 5 |
CELG
Celgene Corp
CELG
|
$7.13M |
Top Sells
| 1 |
LIFE
LIFE TECHNOLOGIES CORP COM STK (DE)
LIFE
|
$8.1M |
| 2 |
Vodafone
VOD
|
$2.43M |
| 3 |
GMCR
KEURIG GREEN MTN INC
GMCR
|
$2.03M |
| 4 |
GE Aerospace
GE
|
$1.87M |
| 5 |
Tractor Supply
TSCO
|
$1.58M |
Sector Composition
| 1 | Healthcare | 29.06% |
| 2 | Technology | 12.48% |
| 3 | Financials | 9.12% |
| 4 | Energy | 7.73% |
| 5 | Consumer Discretionary | 7.01% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
Gilead Sciences
GILD
$140B
| $88.9M | 4.04% | 1,254,806 +213,600 | +21% | +$15.1M |
|
|
2
Amgen
AMGN
$155B
| $75.9M | 3.45% | 615,470 +102,950 | +20% | +$12.7M |
|
|
3
AbbVie
ABBV
$372B
| $62.1M | 2.82% | 1,207,569 +215,378 | +22% | +$11.1M |
|
|
4
Biogen
BIIB
$19.4B
| $58.9M | 2.68% | 192,587 +32,722 | +20% | +$10M |
|
|
CELG
5
DELISTED
Celgene Corp
CELG
| $46.2M | 2.1% | 330,745 +51,065 | +18% | +$7.13M |
|
6
Apple
AAPL
$3.45T
| $40.3M | 1.83% | 75,069 +659 | +0.9% | +$354K |
|
7
Alphabet (Google) Class C
GOOG
$2.58T
| $34.9M | 1.58% | 31,271 +1,342 | +4% | +$1.5M |
|
8
Microsoft
MSFT
$3.77T
| $28M | 1.27% | 683,894 +8,572 | +1% | +$351K |
|
9
Exxon Mobil
XOM
$487B
| $26.3M | 1.2% | 269,456 -6,510 | -2% | -$636K |
|
10
Johnson & Johnson
JNJ
$427B
| $25.3M | 1.15% | 257,772 +37,207 | +17% | +$3.65M |
|
|
ALXN
11
DELISTED
Alexion Pharmaceuticals Inc
ALXN
| $24.7M | 1.12% | 162,080 +29,066 | +22% | +$4.42M |
|
12
Amazon
AMZN
$2.44T
| $19.6M | 0.89% | 58,133 +1,771 | +3% | +$596K |
|
13
Regeneron Pharmaceuticals
REGN
$61.5B
| $19.4M | 0.88% | 64,697 +10,879 | +20% | +$3.27M |
|
14
Pfizer
PFE
$141B
| $18.5M | 0.84% | 576,381 +78,453 | +16% | +$2.52M |
|
15
Illumina
ILMN
$15.8B
| $15.4M | 0.7% | 103,364 +20,512 | +25% | +$3.05M |
|
16
Meta Platforms (Facebook)
META
$1.86T
| $15.3M | 0.69% | 253,525 +10,200 | +4% | +$614K |
|
17
Merck
MRK
$210B
| $15.2M | 0.69% | 268,214 +40,842 | +18% | +$2.32M |
|
18
Intel
INTC
$107B
| $15.2M | 0.69% | 588,104 +146,879 | +33% | +$3.79M |
|
19
Chevron
CVX
$324B
| $14.5M | 0.66% | 122,120 -2,199 | -2% | -$261K |
|
20
Wells Fargo
WFC
$263B
| $13.7M | 0.62% | 274,674 +55,318 | +25% | +$2.75M |
|
21
Vertex Pharmaceuticals
VRTX
$100B
| $13.6M | 0.62% | 192,587 +34,251 | +22% | +$2.42M |
|
22
JPMorgan Chase
JPM
$829B
| $13.5M | 0.61% | 222,780 +45,176 | +25% | +$2.74M |
|
23
eBay
EBAY
$41.4B
| $11.4M | 0.52% | 207,140 +5,144 | +3% | +$284K |
|
24
Qualcomm
QCOM
$173B
| $11.2M | 0.51% | 142,392 +2,516 | +2% | +$198K |
|
25
Schlumberger
SLB
$55B
| $10.8M | 0.49% | 110,632 -2,068 | -2% | -$202K |
|